1. Home
  2. LSCC vs MEDP Comparison

LSCC vs MEDP Comparison

Compare LSCC & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lattice Semiconductor Corporation

LSCC

Lattice Semiconductor Corporation

SELL

Current Price

$122.96

Market Cap

17.2B

Sector

Technology

ML Signal

SELL

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

SELL

Current Price

$620.11

Market Cap

17.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
LSCC
MEDP
Founded
1983
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Commercial Physical & Biological Resarch
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.2B
17.2B
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
LSCC
MEDP
Price
$122.96
$620.11
Analyst Decision
Strong Buy
Hold
Analyst Count
14
14
Target Price
$164.21
★ $595.92
AVG Volume (30 Days)
★ 1.8M
230.3K
Earning Date
11-02-2026
10-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 20.98
EPS
0.29
★ 8.53
Revenue
★ $385,961,000.00
N/A
Revenue This Year
$75.77
$12.72
Revenue Next Year
$45.13
$6.33
P/E Ratio
$432.50
★ $71.77
Revenue Growth
N/A
★ N/A
52 Week Low
$60.50
$373.00
52 Week High
$157.01
$677.90

Technical Indicators

Market Signals
Indicator
LSCC
MEDP
Relative Strength Index (RSI) 48.50 56.15
Support Level $111.89 $565.78
Resistance Level $126.35 $632.08
Average True Range (ATR) 4.31 18.61
MACD 0.01 -1.09
Stochastic Oscillator 28.26 58.18

Price Performance

Historical Comparison
LSCC
MEDP

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: